CCT241736 T4428
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3, CCT241736, an advanced analog of CCT137690, is a preclinical development candidate for the tre
CAS nr:
1402709-93-6
Purity:
98%
Molecular Weight:
456,37
SMILES:
Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1
Formula:
C22H23Cl2N7
Pathway:
Chromatin/Epigenetic,Cell Cycle/Checkpoint,Angiogenesis,Tyrosine Kinase/Adaptors
Target:
Aurora Kinase,Aurora Kinase,FLT,FLT
